Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 2Recruiting 2Completed 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 22Breast Neoplasms 8Stomach Neoplasms 7Lung Neoplasms 7Small Cell Lung Carcinoma 5Rectal Neoplasms 5Pancreatic Neoplasms 5Colorectal Neoplasms 5Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Esophageal Squamous Cell Carcinoma 4Recurrence 3NSCLC 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Muscle-invasive Bladder Cancer 2Multiple Myeloma 2Mesothelioma, Malignant 2Limited Stage Small Cell Lung Cancer 2Leukemia, Myeloid, Acute 2Esophageal Neoplasms 2Urologic Neoplasms 1Upper Tract Urothelial Carcinoma 1Thymus Neoplasms 1Sleep Initiation and Maintenance Disorders 1Resectable Non-small Cell Lung Cancer 1Pathologic Complete Response 1

Interventions

Carboplatin 3Radiotherapy, Intensity-Modulated 2Radiotherapy 2selinexor 1ponatinib 1poly ICLC 1pemigatinib 1neratinib 1donafenib 1cobimetinib 1ceritinib 1cemiplimab 1brigatinib 1abemaciclib 1Thymopentin 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Radiation 1Pluvicto 1Platinum Compounds 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Neck Dissection 1NF protocol 1Magnetic Resonance Spectroscopy 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma × Drug Therapy × Clear all
NCT07135882 2025-08-22

PRIME-Lung

Trans Tasman Radiation Oncology Group

Phase 3 Not yet recruiting
420 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡